Natural Attenuation and Biostimulation for In Situ Treatment of 1,2-Dibromoethane (EDB)

Abstract

1,2-Dibromoethane (EDB) is a suspected human carcinogen and a contaminant of concern (COC)for the Department of Defense (DoD). Because analytical methods for volatile organic compounds(VOCs) often used at fuel-related sites (e.g., EPA 8260B) have detection limits greater than the Federal maximum contaminant level (MCL) for EDB of 0.05 g/L, the extent of EDB contamination at military and civilian sites is unclear and may be underappreciated. Objectives of this DoD ESTCP Project were to: (1) evaluate EDB attenuation, particularly using novel compound specific isotope analysis (CSIA) tools; and (2) determine whether biostimulation orbioaugmentation could effectively enhance in situ treatment of EDB.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 2022
Accession Number
AD1187025

Entities

People

  • Graig Lavorgna
  • Paul B. Hatzinger
  • Paul Koster Van Groos
  • Paul Philip
  • Tomasz Kuder

Organizations

  • University of Oklahoma

Tags

Communities of Interest

  • Human Systems

DTIC Thesaurus Topics

  • Air Force
  • Alkanes
  • Alkenes
  • Biodegradation
  • Chemical Synthesis
  • Chemistry
  • Environment
  • Environmental Protection
  • Fatty Acids
  • Groundwater
  • Heavy Water
  • Ketones
  • Materials Science
  • Measurement
  • Organic Chemistry
  • Waste Management

Fields of Study

  • Environmental science

Readers

  • Groundwater Contamination Remediation.